Bronchopulmonary Dysplasia Market is expected to portray promising scenarios, as it is estimated to reach $661.7 million in 2030 which was initially valued at around $344.98 million in 2021, thereby registering a CAGR of nearly 6.1% from 2022 to 2030. During the COVID-19 epidemic, the Bronchopulmonary Dysplasia Market has played a critical role. To deal with the worldwide issue, traditional...